NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: LIXTE Biotechnology Sponsors Good Health Summit at Morehouse College
TL;DR
LIXTE Biotechnology's sponsorship of the Good Health Summit positions the company to gain community trust and showcase its cancer drug LB-100 to key stakeholders in health equity.
LIXTE Biotechnology is sponsoring an invitation-only summit at Morehouse College that addresses health disparities through discussions on cancer, mental health, and wellness for Black men and families.
This summit advances health equity by connecting scientific innovation with communities most impacted by disparities, making tomorrow better through improved wellness and cancer care.
De La Soul's evolution from musical pioneers to wellness advocates inspired this summit, blending culture and science to tackle health issues like cancer and mental health.
Found this article helpful?
Share it with your network and spread the knowledge!
LIXTE Biotechnology Holdings (NASDAQ: LIXT) is sponsoring the inaugural Good Health: Mind, Body & Soul Summit at Morehouse College, an event focused on advancing health equity for Black men and families through discussions on various health topics.
The summit aligns with LIXTE's mission as a clinical-stage pharmaceutical company advancing cancer care through its oncology compound LB-100, while creating a space to connect scientific innovation with communities most impacted by health disparities.
The summit is scheduled for February 19 at Morehouse College in Atlanta, Georgia.
The summit is sponsored by LIXTE Biotechnology Holdings, developed in collaboration with Blacksmith holdings, inspired by De La Soul's legacy, and brings together leaders in health, culture, science, and community.
Discussions will span cancer, heart disease, mental health, addiction, sleep, relationships, and intergenerational wellness.
LIXTE is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing/commercializing cancer therapies, with its lead compound LB-100 being a first-in-class PP2A inhibitor.
LB-100 is a first-in-class PP2A inhibitor that has demonstrated to be well-tolerated in cancer patients at doses associated with anti-cancer activity, with potential to significantly enhance chemotherapies and immunotherapies.
The latest news and updates relating to LIXT are available in the company's newsroom at https://ibn.fm/LIXT, and more information about the company can be found at www.lixte.com.
The summit is inspired by the music, legacy, and lived experiences of De La Soul, specifically their song 'Good Health' written following the passing of founding member David Jolicoeur (Trugoy the Dove), reflecting the group's evolution from musical pioneers to wellness advocates.
Proof-of-concept clinical trials are currently in progress for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer.
Curated from InvestorBrandNetwork (IBN)
